Sickle Cell Disease Knowledge and Reproductive Decisions: A Saudi Cross-Sectional Study

References

• Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ. 2006;333(7573):831–834. doi:10.1136/bmj.38982.704931.AE
   PubMed Web of Science ®Google Scholar
• Claussnitzer M, Cho JH, Collins R, et al. A brief history of human disease genetics. Nat Res. 2020;577:179–189. doi:10.1038/s41586-019-1879-7
   Google Scholar
• Alsaeed ES, Farhat GN, Assiri AM, et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015. J Epidemiol Glob Health. 2018;7:S41–7. doi:10.1016/j.jegh.2017.12.001
   PubMed Web of Science ®Google Scholar
• Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and β-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health. 2011;1(1):61–68. doi:10.1016/j.jegh.2011.06.002
   PubMedGoogle Scholar
• Adam SS, Flahiff CM, Kamble S, Telen MJ, Reed SD, de Castro LM. Depression, quality of life, and medical resource utilization in sickle cell disease. Blood Adv. 2017;1(23):1983–1991. doi:10.1182/bloodadvances.2017006940
   PubMed Web of Science ®Google Scholar
• Tran H, Gupta M, Gupta K Targeting novel mechanisms of pain in sickle cell disease; 2017. Available from: http://ashpublications.org/blood/article-pdf/130/22/2377/1403522/blood782003.pdf. Accessed March 16, 2023.
   Google Scholar
• Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31:289–293. doi:10.4103/0256-4947.81540
   PubMed Web of Science ®Google Scholar
• Piccin A, Fleming P, Eakins E, McGovern E, Smith OP, McMahon C. Sickle cell disease and dental treatment. J Ir Dent Assoc. 2008;54(2):75–79.
   PubMedGoogle Scholar
• Budreviciute A, Damiati S, Sabir DK, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.574111
   PubMed Web of Science ®Google Scholar
• Meyer BF. Strategies for the prevention of hereditary diseases in a highly consanguineous population. Ann Hum Biol. 2005;32:174–179. doi:10.1080/03014460500075217
   PubMed Web of Science ®Google Scholar
• Alsalman M, Alkhalifa H, Alkhalifa A, et al. Hydroxyurea usage awareness among patients with sickle-cell disease in Saudi Arabia. Health Sci Rep. 2021;4:4. doi:10.1002/hsr2.437
   Google Scholar
• Piccin A, Murphy C, Eakins E, et al. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment. Eur J Haematol. 2019;102(4):319–330. doi:10.1111/ejh.13212
   PubMed Web of Science ®Google Scholar
• Yawn BP, Buchanan GR, Afenyi-A Nnan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048. doi:10.1001/jama.2014.10517
   PubMed Web of Science ®Google Scholar
• Jagadeeswaran R, Rivers A. Evolving treatment paradigms in sickle cell disease. Hematology. 2017;2017(1):440–446. doi:10.1182/asheducation-2017.1.440
   PubMedGoogle Scholar
• Booth A, Bonham V, Porteus M, Ormond KE. Treatment decision-making in sickle cell disease patients. J Community Genet. 2022;13(1):143–151. doi:10.1007/s12687-021-00562-z
   PubMed Web of Science ®Google Scholar
• Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84(6):323–327. doi:10.1002/ajh.21408
   PubMed Web of Science ®Google Scholar
• Bin Zuair A, Aldossari S, Alhumaidi R, Alrabiah M, Alshabanat A. The burden of sickle cell disease in Saudi Arabia: a single-institution large retrospective study. Int J Gen Med. 2023;13(16):161–171. doi:10.2147/IJGM.S393233
   Google Scholar
• Schultz CL, Tchume-Johnson T, Jackson T, Enninful-Eghan H, Schapira MM, Smith-Whitley K. Reproductive intentions in mothers of young children with sickle cell disease. Pediatr Blood Cancer. 2020;67:5. doi:10.1002/pbc.28227
   Web of Science ®Google Scholar
• AlHamdan NAR, AlMazrou YY, AlSwaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6):372–377. doi:10.1097/GIM.0b013e318065a9e8
   PubMed Web of Science ®Google Scholar
• Treadwell MJ, Mcclough L, Vichinsky E. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc. 2006;98:704–710.
   PubMed Web of Science ®Google Scholar
• Long KA, Thomas SB, Grubs RE, Gettig EA, Krishnamurti L. Attitudes and beliefs of African-Americans toward genetics, genetic testing, and sickle cell disease education and awareness. J Genet Couns. 2011;20(6):572–592. doi:10.1007/s10897-011-9388-3
   PubMed Web of Science ®Google Scholar
• Sullivan-Pyke CS, Senapati S, Mainigi MA, Barnhart KT. In vitro fertilization and adverse obstetric and perinatal outcomes. Semin Perinatol. 2017;41(6):345–353.
   PubMed Web of Science ®Google Scholar
• Collins SC, Xu X, Mak W. Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization. J Assist Reprod Genet. 2017;34(11):1515–1522. doi:10.1007/s10815-017-1001-8
   PubMed Web of Science ®Google Scholar
• Oyewo A, Salubi-Udu J, Khalaf Y, et al. Preimplantation genetic diagnosis for the prevention of sickle cell disease: current trends and barriers to uptake in a London teaching hospital. Hum Fertil. 2009;12(3):153–159. doi:10.1080/14647270903037751
   Web of Science ®Google Scholar
• Almaslami F, Aljunid SM. Cost-effectiveness of assisted reproductive technologies in Saudi Arabia: comparing in vitro fertilization with intrauterine insemination. SAGE Open Med. 2020;13(8):2050312120931988.
   Google Scholar